Gelatin is used in the pharmaceutical industry to encapsulate active agents. It protects against oxidation and overly quick release. Tiny pores in the material have a significant influence on this, yet they are difficult ...
General Physics
Dec 29, 2014
0
0
(Phys.org) —Herceptin and camptothecin are both powerful anticancer agents with key characteristics that limit their effectiveness in treating cancer. Patients treated with Herceptin, a monoclonal antibody that targets ...
Bio & Medicine
Jul 15, 2013
0
0
Scientists in India are reporting successful laboratory tests of a new and potentially safer alternative to silver-based gels applied to the skin of burn patients to treat infections. With names like silver sulfadiazine and ...
Bio & Medicine
Jul 22, 2009
1
0
In future, it will be much easier to produce some active pharmaceutical substances and chemical compounds than was the case to date. An international team working with chemists from the Max-Planck-Institut für Kohlenforschung ...
Materials Science
Sep 13, 2013
0
0
Scientists working at the Institut Laue-Langevin have shown that the charge of gold nanoparticles, identified by major pharmaceutical companies as a drug delivery agent of the future for the treatment of cancer, affects how ...
Bio & Medicine
Jun 7, 2013
0
1
Scientists at The Scripps Research Institute (TSRI) have invented a set of chemical tools that is radically simplifying the creation of potential new drug compounds.
Biochemistry
Nov 28, 2012
0
0
(Phys.org)—A joint research effort by the Friedrich-Loeffler-Institute and pharmaceutical company CureVac, both based in Germany, has resulted in the creation of a new type of flu vaccine. The vaccine, as the team describes ...
(PhysOrg.com) -- The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers. ...
Analytical Chemistry
Nov 26, 2009
0
0
Researchers from ETH Zurich have filed a patent application for a method to test the biological activity of one of the strongest toxins known, the botulinum neurotoxin. If the procedure is adopted by the pharmaceutical industry, ...
Cell & Microbiology
Jan 18, 2013
1
0
(Phys.org) —There's hope for patients with myotonic dystrophy. A new small molecule developed by researchers at the University of Illinois has been shown to break up the protein-RNA clusters that cause the disease in living ...
Biochemistry
Apr 30, 2013
0
0
